Actively Recruiting
Prevalence of Postpartum Depression Among Patients of the CHUM GARE Clinic
Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2026-02-23
100
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to estimate how common postpartum depression (PPD) is among patients attending a high-risk pregnancy clinic at the CHUM. It also evaluates the use of a standardized screening process that combines the Edinburgh Postnatal Depression Scale (EPDS) with a clinical decision-support algorithm to guide appropriate medical follow-up. The study explores clinical factors linked to higher EPDS scores, including age, lifestyle habits, medical and obstetric history, and newborn care practices. The study includes 100 postpartum patients who have given birth within the last 4 weeks to 6 months and who attend routine postpartum visits at the clinic. All participants will complete the EPDS screening during their visit. If their score is 13 or higher, a clinical algorithm will guide referrals for medical or psychosocial care. Follow-up telephone calls will be conducted at two and six weeks after screening to check if referrals were completed and to assess the time taken to access services. Participants will undergo evaluations that include the initial EPDS screening and follow-up calls. Researchers will review clinical and obstetric data to identify factors associated with higher depression scores. The main outcome is the prevalence of postpartum depression based on EPDS scores at baseline. Secondary outcomes include referral orientation, repeat EPDS scores at two weeks for certain patients, and timing of contact with support services. The study runs from October 2025 to January 2027 and involves systematic monitoring to support early detection and care for postpartum depression.
CONDITIONS
Brief Title
Prevalence of Postpartum Depression Among Patients of the CHUM GARE Clinic
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or more
- Patient who gave birth within the last 4 weeks to 6 months
- Ability to understand French or English and complete the EPDS questionnaire
- Physically present at their post-partum visit at the clinic
You will not qualify if you...
- Inability to comprehend and/or complete the EPDS
- Declines participation or does not provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during scheduled postpartum clinic visit
Duration - Day 0 (initial postpartum visit)
Participants complete the Edinburgh Postnatal Depression Scale (EPDS) to assess symptoms of postpartum depression. Participants with elevated scores receive medical orientation based on a standardized clinical algorithm.
1 baseline visit (in-person)
Duration - 6 weeks after initial screening
Participants with elevated EPDS scores are followed up by telephone to confirm completion of recommended referrals and evaluate time to access services. Repeat EPDS assessments are conducted for some participants at 2 weeks.
2 follow-up telephone calls at 2 weeks and 6 weeks after initial visit
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada, H2X 3E4
Actively Recruiting
Research Team
A
Anne Lavoie, MD
J
Julie Desroches, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here